An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis by Yi-Ming Ma, Shu-Xia Cheng, Ming-Chuan Zhang, Hui-Ying Zhang, Jun-Jiao Gu, Pan-Pan Zhao, Hong Ge

Get full text